XLRN

Acceleron Pharma Inc.
XLRN

Overview Fund Activity
Delisted

XLRN was delisted on the 19th of November, 2021.

Back to rankings

183 hedge funds and large institutions have $2.57B invested in Acceleron Pharma Inc. in 2019 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 61 increasing their positions, 60 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
183
Holders Change
+11
Holders Change %
+6.4%
% of All Funds
3.61%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.12%
New
35
Increased
61
Reduced
60
Closed
19
Calls
$20.4M
Puts
$10.4M
Net Calls
+$9.96M
Net Calls Change
+$12.5M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$422M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$129M
3
HM
3
HealthCor Management
New York
$17.1M
4
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$14.5M
5
GLA
5
Great Lakes Advisors
Illinois
$7.24M

Top Sellers

1
GPP
1
Great Point Partners
Connecticut
$53M
2
FCM
2
Farallon Capital Management
California
$106M
3
Alkeon Capital Management
3
Alkeon Capital Management
New York
$30.6M
4
AG
4
Artal Group
Luxembourg
$63.6M
5
BlackRock
5
BlackRock
New York
$259M
Name Holding Trade Value Shares
Change 		Shares
Change %
Fifth Third Bancorp
201
Fifth Third Bancorp
Ohio
– -$2K -59 Closed
5 6 7 8
9